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Vulval morphogenesis in Caenorhabditis elegans generates a stack of toroidal cells enclosing a tubular lumen. Mutation of egl-26 is associated
with malformation of vulF, the most dorsal toroid in the stack, resulting in a blocked lumen and an egg-laying defect. Here we present evidence
that vulF retains the expected gene expression pattern, functions in signaling to the uterus and retains proper polarity when egl-26 is mutated, all
suggesting that mutation of egl-26 specifically results in aberrant morphogenesis as opposed to abnormal fate specification. Recent computational
analysis indicates that EGL-26, which was previously characterized as novel, belongs to the LRAT (lecithin retinol acyltransferase) subfamily of
the NlpC/P60 superfamily of catalytic proteins. Via site-directed mutagenesis, we demonstrate a requirement of the putative catalytic residues for
EGL-26 function in vivo. We also show that mutation of conserved serine 275 perturbs the apical membrane localization and the function of the
EGL-26 protein. Additional mutagenesis of this residue suggests that EGL-26 attains its membrane localization via a mechanism distinct from that
of LRAT.
© 2007 Elsevier Inc. All rights reserved.Keywords: LRAT; Hrasls3; Morphogenesis; Organogenesis; Tubulogenesis; PalmitoyltransferaseIntroduction
Formation of internal lumens is vital to the function of many
organ systems, and vulval morphogenesis in Caenorhabditis
elegans is an excellent tractable model for elucidating the
molecular mechanisms controlling one type of tubular organo-
genesis. Vulva morphogenesis is initiated upon production of an
EGF-like signal by the gonadal anchor cell (AC) (Kimble, 1981;
Sulston and White, 1980). In response to this signal, three
ventral hypodermal cells undergo a series of divisions. Their
twenty-two progeny then complete a complex series of cell
shape changes, cell migrations and cell fusions (Sharma-
Kishore et al., 1999), resulting in the formation of a stack of
mostly multinucleate toroidal cells surrounding a central lumen.
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laying. During vulval morphogenesis, the AC sits atop of the
developing vulval lumen and occupies the space that will
become the lumen in the most dorsal toroidal cell, which is
called vulF (Sharma-Kishore et al., 1999; Sherwood and
Sternberg, 2003). The AC subsequently fuses to the uterine
seam cell leaving only the thin uterine seam cell cytoplasm
between the vulval and uterine lumens (Newman et al., 1996).
This thin laminar process is presumably broken when egg-
laying begins, creating an uninterrupted passageway from the
uterus to the environment.
The egl-26 gene was first identified in a screen for mutants
with egg-laying (Egl) defects (Trent et al., 1983). New alleles
were found in a screen for Egl mutants associated with specific
vulval morphology defects (Hanna-Rose and Han, 2002). In
egl-26 mutants, the vulF cell adopts a “closed” morphology
with no inner lumen as opposed to the expected toroidal
morphology. This results in a blockage between the vulval and
uterine lumens, a connection of gonad (Cog) defect.
To better understand the role of egl-26 in the process of
morphogenesis, we have extensively examined this novel
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specifically during morphogenesis rather than during specifica-
tion of vulF fate (Hanna-Rose and Han, 2002). We will present
data to support this model. We also demonstrate that mutation of
egl-26 does not perturb polarization of vulval cells or
penetration of vulF by the AC, suggesting that the morphology
defect manifests quite late in vulva development.
EGL-26 shares sequence motifs with the NlpC/P60 super-
family of enzymes (Anantharaman and Aravind, 2003). This
family includes proteins that range in biochemical function
from cell wall peptidases in prokaryotes to palmitoyltrans-
ferases in mammals (Anantharaman and Aravind, 2003). EGL-
26 belongs to a subfamily that includes the mammalian proteins
LRAT (lecithin retinol acyltransferase) and Hrasls3 (HRAS-like
suppressor 3) as well as the picornovirus 2A proteins
(Anantharaman and Aravind, 2003; Hughes and Stanway,
2000). The mammalian protein most closely related to EGL-26
is LRAT, which is a biochemically well-characterized palmi-
toyltransferase (Anantharaman and Aravind, 2003; Rando,
2002; Xue et al., 2004). LRAT palmitoylates all-trans-retinol
(vitamin A), producing all-trans-retinyl esters necessary for
rhodopsin chromophore production in the retinal pigment
epithelium (Barry et al., 1989; MacDonald and Ong, 1988;
Saari and Bredberg, 1989; Shi et al., 1993). LRATalso catalyzes
the palmitoylation of RPE65 (retinal pigment epithelial protein
of 65 kDa), regulating chromophore synthesis during the light–
dark cycle (Xue et al., 2004). Mutation of LRAT is associated
with an early-onset retinal dystrophy (Thompson et al., 2001).
Much less is known about Hrasls3, which was identified in a
screen for tumor suppressors in H-ras-transformed cell lines
(Sers et al., 1997). Because mutation of egl-26 results in such a
specific and easily studied phenotype, the C. elegans vulva
provides an excellent model for studying biological roles of the
NlpC/P60 family in animal development.
The defining motifs of this family are the H-box domain and
the NC domain (Fig. 1) (Anantharaman and Aravind, 2003;
Hughes and Stanway, 2000). The H-box contains a conserved
histidine, and the NC domain contains a conserved cysteine
(Hughes and Stanway, 2000). These residues are essential for
catalytic function of this family of enzymes (Anantharaman and
Aravind, 2003; Xue et al., 2004), and we present evidence thatFig. 1. Schematic comparing protein motifs between EGL-26 and LRAT. The positio
that characterize eukaryotic NlpC/P60 superfamily proteins are indicated. The definin
domain, respectively. The thick black line represents the LRAT transmembrane doma
mutations that they cause are indicated beneath the conserved amino acids that they
frame deletion in the tm1244 allele, which is predicted to encode a truncated protein th
the frame shift. Sequence identity/similarity between EGL-26 and LRAT is 34/69%these residues are essential for the developmental role of EGL-
26 in vivo.
Enzymes in the NlpC/P60 superfamily are frequently
associated with or function at the membrane (Anantharaman
and Aravind, 2003; Hughes and Stanway, 2000). For example, a
predicted C-terminal transmembrane domain of LRATspans the
membrane, targets the protein to the ER and is required for
acyltransferase function in COS-7 cells (Moise et al., 2007).
Interestingly, although ELG-26 does not contain a predicted
transmembrane domain, EGL-26∷GFP expression is highly
concentrated at the apical membrane (e.g., Fig. 5B) (Hanna-
Rose and Han, 2002). We present evidence correlating EGL-26
membrane localization with function during development.
Materials and methods
Maintenance and culture of C. elegans strains
Unless otherwise stated, strains were grown under standard conditions at 20°
(Brenner, 1974). We used the following strains, alleles and transgenes: N2 wild-
type; PS4308 syIs107[unc-119(+)+ lin-3(delta-pes-10)∷GFP]; MH1371 kuIs38
[dpy-20(+)+cdh-3∷GFP]; LG II: egl-26(ku211, ku228, n481) and egl-26
(tm1244) (obtained from the National Bioresource Project, Tokyo Women's
Medical University, Japan), MT681 nDf3/lin-31(n301) bli-2(e768) (Greenwald
and Horvitz, 1980), BL5715 inIs179[ida-1∷GFP] (Zahn et al., 2001); CB5584
mIs12[myo-2∷GFP, pes-10∷GFP, F22B7.9∷GFP]; LG III: unc-119(ed3); LG
IV: PS3239 dpy-20(e1282) syIs49[dpy-20(+)+ zmp-1∷GFP)] (Inoue et al.,
2002); LG V: him-5(e1490). Additional genetic information is available at
http://www.wormbase.org.
Cloning and genetics
To create vectors encoding EGL-26 mutant proteins, we performed site-
directed mutagenesis of pWH15[EGL-26∷GFP] (Hanna-Rose and Han, 2002)
by recombinant PCR. We used primers at the site of mutagenesis (Table 1) and
the following outside primers:
for H166 and H178 recombinant PCR products:
PflM I F TTCGATGATCCACCAATTGG
Sac I R CAAAATTTGCCGAGCTCGGC
for C261 and S275F recombinant PCR products:
Sac I F GTCGTCGACGAGCTCGGCAAATTTTGAGATTTACC
BamH I R CGGGATCCCGAAGAAGTACTGCTGCTCGC
for S275E, S275A and S275T recombinant PCR products:
COG-4 5′ SEQ GTCTCGTGACCTCATCAGCC
GFP 3′ past Nco1 GTAGTGACAAGTGTTGGCns of the conserved H-box (light grey boxes) and NC domains (dark grey boxes)
g histidine (H) and asparagine/cysteine (NC) are underlined in the H-box and NC
in. EMS induced alleles of egl-26 (ku228, ku211 and n481) and the substitution
alter. The line below the EGL-26 sequence represents the position of the out-of-
at includes residues 1 to 129 plus a leucine prior to the stop codon introduced by
in the H-box and is 38/59% in the NC domain.
Table 1
Mutagenesis primers
Construct Mutagenesis primers
pH166A
[EGL-26(H166A)∷GFP]
GGTGTAAAATTCTATGCCAGTGGAATTTATGC
GCATAAATTCCACTGGCATAGAATTTTACACC
pH178A
[EGL-26(H178A)∷GFP]
GGAATGTGCTACGCTTTTGTCTGC
GCAGACAAAAGCGTAGCACATTCC
pC261A
[EGL-26(C261A)∷GFP]
CGTTGCAACGCCCAACATTTCTCATCGG
CCGATGAGAAATGTTGGGCGTTGCAACG
pS275F
[EGL-26(S275F)∷GFP]
CCCATTCTTTTATGACATGAC
GTCATGTCATAAAAGAATGGG
pS275A
[EGL-26(S275A)∷GFP]
GGCGTCCCATTCGCTTATGACATGAC
GAAGTCATGTCATAAGCGAATGGGAC
pS275E
[EGL-26(S275E)∷GFP]
GGCGTCCCATTCGAATATGACATGACTTC
GAAGTCATGTCATATTCGAATGGGACGCC
pS275T GGCGTCCCATTCACTTATGACATGAC
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BamH I or Sac I and Age I and ligated into the vector pWH15, from which the
wild-type fragment had been removed.
To create a plasmid encoding EGL-26(S275F)∷GFP∷CAAX, we digested
pWH15(S275F) with Xho I and Apa I and isolated two fragments (a 5 kb pair
Xho I fragment and a 4 kb pair Apa I–Xho I). We also digested vector GFP-PM
(Portereiko and Mango, 2001) with Xho I and Apa I to isolate a fragment
encoding the C-terminus of GFP with a CAAX motif. We ligated this fragment
to the 4 kb pair fragment from pWH15, digested the product with Xho I and
inserted the 5 kb pair Xho I fragment from pWH15(S275F) to create pRK3
[EGL-26(S275F)∷GFP∷CAAX].
To create a construct encoding EGL-26∷GFP∷CAAX, we digested pRK3
and pWH15 with Apa I and BamH I. We isolated a 1.8-kb pair fragment from
pRK3 containing the GFP∷CAAX sequence, but without the S275F mutation.
We then ligated this fragment to an 8.9-kb pair fragment isolated from pWH15
after digestion to create pKE4[EGL-26∷GFP∷CAAX].
We sequenced each construct and created transgenic strains using germline
transformation (Mello et al., 1991) (Table 2). All constructs were co-injected
with unc-119+ at 60 ng/μl (Maduro and Pilgrim, 1995).
Scoring of egg-laying and cell fate phenotypes
To determine if in vitro mutagenized EGL-26∷GFP fusion proteins could
rescue egl-26 mutants, we placed transgenes (see Table 2) in egl-26(ku228) or
egl-26(ku211) backgrounds by direct injection or by mating and scored for
egg-laying ability. We scored animals as egg-laying defective (Egl) if they laid
[EGL-26(S275T)∷GFP] GAAGTCATGTCATAAGTGAATGGGACTable 2
Transgenic lines
Construct Genotype injec
pH166A [EGL-26(H166A)∷GFP] unc-119(ed3)
pH178A [EGL-26(H178A)∷GFP] unc-119(ed3)
pC261A [EGL-26(C261A)∷GFP] unc-119(ed3)
pWH15 [EGL-26∷GFP] egl-26(ku228)
pS275F [EGL-26(S275F)∷GFP] Line 2 egl-26(ku211)
pS275F [EGL-26(S275F)∷GFP] Line 4 egl-26(ku211)
pS275E [EGL-26(S275E)∷GFP] Line 1 egl-26(ku211)
pS275E [EGL-26(S275E)∷GFP] Line 2 egl-26(ku211)
pS275A [EGL-26(S275A)∷GFP] Line 1 egl-26(ku211)
pS275A [EGL-26(S275A)∷GFP] Line 2 egl-26(ku211)
pS275T [EGL-26(S275T)∷GFP] Line 1 egl-26(ku211)
pS275T [EGL-26(S275T)∷GFP] Line 2 egl-26(ku211)
pWH15 [EGL-26∷GFP] egl-26(ku211)
pRK3 [EGL-26(S275F)∷GFP∷CAAX] Line 1 unc-119(ed3)
pRK3 [EGL-26(S275F)∷GFP∷CAAX] Line 2 egl-26(ku211)
pKE4 [EGL-26∷GFP∷CAAX] Line 1 egl-26(ku211)
pKE4 [EGL-26∷GFP∷CAAX] Line 2 egl-26(ku211)no eggs or less than 20 eggs prior to forming the “bag of worms” phenotype
caused by unlaid eggs hatching inside the mother.
To test if egl-26(tm1244) behaved as a null, we mated egl-26(tm1244) mIs12;
him-5(e1490) males to nDf3/lin-31 bli-2 hermaphrodites. We picked GFP-
positive cross progeny and scored for egg-laying ability as previously described.
We then discarded data from any animalwith Bli progeny, thus including only egl-
26(tm1244)/nDf3 animals but not egl-26(tm1244)/lin-31 bli-2 animals.
To assay cell fate specification and AC invasion, we mated egl-26(ku211), him-
5(e1490) males into PS4308 syIs107[lin-3∷GFP], PS3239 dpy-20(e1282) syIs49
[zmp-1∷GFP], BL5715 inIs179[ida-1∷GFP], and MH1371 kuIs38[cdh-3∷GFP)]
and examined GFP expression as compared to control strains.
Statistical analysis
To determine if the percentage of animals that lay eggs is statistically
significant between different populations, we used the following equations
(Milton, 1992):
L1 ¼ p z½pð1 pÞ=nð1=2Þ and L2 ¼ pþ z½pð1 pÞ=nð1=2Þ;
where z=1.96 for a 95% confidence interval, L1 is the lower bound and L2 is the
upper bound, p is the egg-laying proportion, and n is the sample size. Graphs
have error bars representing 95% confidence intervals.
Immunofluorescence
Fixed and permeabilized animals (Bettinger et al., 1996) were incubated in
rabbit anti-PAR-6 antibody at a dilution of 1:10 in 2% NGS in 1× Buffer A at
4 °C for 24 h. We then washed the animals four times for 10 min in 1× Buffer A
and incubated them in Cy-3-conjugated goat anti-rabbit at a 1:100 dilution for
3 h at room temperature. Finally we the washed samples four times for 10 min in
1× Buffer A, twice for 1 h and then overnight. We mounted stained animals in
80% glycerol with anti-bleaching agents and visualized by epifluorescence on a
Zeiss Axioplan 2.Results
Developmental role of EGL-26
A specific vulF morphology defect is associated with all
EMS-induced alleles of egl-26 (Hanna-Rose and Han, 2002).
However, none of the EMS-induced alleles are a predicted
molecular null (Fig. 1), nor are they fully penetrant for theted Concentration (ng/μl) Transgene
20 psEx37
20 psEx36
20 psEx43
15 psEx84
10 psEx112
10 psEx113
10 psEx77
10 psEx123
10 psEx85
10 psEx111
10 psEx86
10 psEx106
10 psEx110
10 psEx25
10 psEx107
10 psEx64
10 psEx109
199K.A. Estes et al. / Developmental Biology 308 (2007) 196–205morphology or Egl defects (Hanna-Rose and Han, 2002). We
obtained egl-26 deletion allele tm1244 from the National
Bioresource Project at Tokyo Women's Medical University,
Japan. tm1244 deletes 603 bp of egl-26, including the entire H-
box domain. The deletion results in a frame shift that introduces
a leucine codon and a stop codon immediately after codon 129.
Thus, tm1244 is predicted to encode a protein truncated after a
total of 130 amino acids without any of the domains conserved
in the NlpC/P60 family (Fig. 1). egl-26(tm1244) animals have a
qualitatively and quantitatively similar phenotype (66% Egl,
n=200; 76% Cog, n=62) to the EMS-generated alleles
(Hanna-Rose and Han, 2002). To determine if egl-26(tm1244)
is a complete loss-of-function allele, we scored animals
heterozygous for egl-26(tm1244) and the deficiency nDf3,
which includes the egl-26 locus. egl-26(tm1244)/nDf3 animals
have an egg-laying defect (66% Egl, n=41) indistinguishable
from egl-26(tm1244) (above). This suggests that egl-26
(tm1244) is likely a near-null allele. The incomplete penetrance
of this egl-26 deletion allele suggests that EGL-26 promotes,
but is not always required, to establish proper vulval
morphology.
Phenotypic observation suggested that in egl-26 mutants
vulF resembled the underlying cell called vulE (Hanna-Rose
and Han, 2002). Previous work using a nuclear localized egl-
26p∷GFP(NLS) transcriptional fusion as a marker revealed no
evidence that vulF was adopting a vulE fate in the mutants
(Hanna-Rose and Han, 2002). Here we present further evidence
that no fate transformation has occurred. Although few genes
are expressed differentially in vulE versus vulF (Inoue et al.,
2002), lin-3∷GFP is expressed in vulF but not vulE (Chang et
al., 1999) and zmp-1∷GFP is expressed in vulE but not vulF
(Wang and Sternberg, 2000). We found that both markers retain
their expected expression pattern in egl-26 mutants (Fig. 2).
We have also used a functional assay to examine vulF fate. A
lin-3 EGF signal originating from vulF induces four uterine
cells to adopt an uv1 cell fate. In the absence of vulF, uv1 fate
specification is compromised (Chang et al., 1999). To assay uv1
fate we used ida-1∷GFP, which within the uterus is brightlyFig. 2. Vulva cells are properly specified and vulF retains some function in egl-26(ku
vulE (arrows), and (E, F) ida-1∷GFP in uv1 cells (arrows), which are induced by sign
Scale bar: 10 μm.expressed only in the specified uv1 cells (Zahn et al., 2001).
ida-1∷GFP is expressed normally in all egl-26(ku211) animals
(Fig. 2), not only confirming that lin-3 is likely expressed at the
proper time in vulF but also demonstrating that signaling
interactions between the mutant vulF cell and neighboring cells
are functional. Thus, in combination with previously reported
data, we find no evidence of a fate specification defect in egl-26
mutants. Instead of affecting vulF fate, mutation of egl-26 likely
has a more specific effect on vulF morphogenesis.
Since EGL-26 is distinctly localized to the apical membrane
of vulF in the vulval epithelium (Hanna-Rose and Han, 2002)
and mutation of egl-26 leads to morphological abnormalities in
vulF, we also examined vulF cell polarity in the mutants. PAR-6
is an apical surface protein and is important for establishing
epithelial cell polarity (Hung and Kemphues, 1999; Hurd and
Kemphues, 2003). We used anti-PAR-6 antibody to examine
whether the apico-basal polarity of vulF is compromised in egl-
26 mutants. PAR-6 localizes to the apical surface of vulF in
mutants, even at late stages of morphogenesis when the
morphology defect is obvious (Fig. 3). We conclude that loss
of EGL-26 does not disrupt polarization or cause mis-
localization of other apical markers despite the EGL-26 sub-
cellular localization at the apical membrane.
In wild-type animals, the AC invades the space that will
become the lumen in the vulF toroid and subsequently fuses to
the uterine seam cell (Newman et al., 1996; Sharma-Kishore et
al., 1999). No lumen is evident within the vulF toroid in egl-26
mutants (Hanna-Rose and Han, 2002). To determine if a space
within the future vulF cell was initially invaded and occupied by
the AC in egl-26 mutants, we used cdh-3∷GFP, which allows
clear visualization of the boundaries of the AC throughout L3
and into early L4 larval stages when the AC normally fuses to
the uterine seam cell (Hanna-Rose and Han, 1999; Sherwood
and Sternberg, 2003). AC invasion occurs normally in egl-26
(ku211); the AC clearly makes contact with the developing
vulval lumen (Figs. 3E, F). The AC also fuses with the uterine
seam cell (data not shown) as seen in wild-type animals. Thus,
the observed morphology defect where vulF has no apparent211). Expression of (A, B) lin-3∷GFP in vulF (arrows), (C, D) zmp-1∷GFP in
aling from vulF, in wild-type (top row) and egl-26(ku211)mutants (bottom row).
Fig. 4. The residues predicted to be important for catalysis based on homology to LRA
in EGL-26 and site of GFP fusion; asterisks indicate residues conserved in LRAT tha
(ku228) mutant populations carrying transgenes encoding wild-type EGL-26∷GFP o
percentage is cited within each bar. Error bars indicate a 95% confidence interval. S
Fig. 3. Cell polarity and AC invasion are normal in egl-26(ku211). (A, C)
Differential interference contrast (DIC) photomicrographs and (B, D)
corresponding fluorescent images of animals stained with anti-PAR-6 antibody,
a marker for the apical surface of epithelial cells (Hung and Kemphues, 1999;
Hurd and Kemphues, 2003). Apical localization is obvious in (A, B) N2 wild-
type animals at the early L4 stage and throughout L4 (not shown; Hurd and
Kemphues, 2003). Similarly, PAR-6 is still apically localized in egl-26(ku211)
mutants at the mid to late L4 stage (C, D) after the morphology defect is obvious.
(E, F) Fluorescent images overlaid onto DIC images of the same animal. The AC
comes into close contact with the vulva lumen (arrows) and sits in the middle of
vulF precursor cells in both (E) N2 and (F) egl-26(ku211) animals. Scale bar:
10 μm.
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anchor cell withdraws from this space in the middle of the
developing vulF toroid.
Putative catalytic residues of the H-box and NC domain are
essential for EGL-26 function
In order to determine the significance of the sequence
homology between EGL-26 and LRAT, we assessed the
importance of the conserved residues in the H-box and NC
domain to the biological function of EGL-26. Via site-directed
mutagenesis, we substituted alanine for histidine 166 and
cysteine 261, which are conserved among the family at large
(Anantharaman and Aravind, 2003) and are essential for LRAT
catalytic activity (Jahng et al., 2003; Mondal et al., 2000, 2001;
Xue and Rando, 2004) (Fig. 4). We also mutated His178, which
is conserved between LRAT and EGL-26 but is not important
for LRAT catalytic activity (Mondal et al., 2001) to demonstrate
that any effects are specific to the putative catalytic residues. We
performed the mutagenesis in the context of a GFP fusion
protein. We assayed function of the transgene via restoration of
egg-laying ability in an egl-26(ku228) mutant background and
simultaneously monitored expression and sub-cellular localiza-
tion of the fusion protein via visualization of GFP.
EGL-26∷GFP robustly rescued the egg-laying defect of egl-
26(ku228) animals (Fig. 4). However, EGL-26(H166A)∷GFP
and EGL-26(C261A)∷GFP did not (Fig. 4). In contrast,
mutation of the non-catalytic residue H178 had no effect on
EGL-26 protein activity; EGL-26(H178A)∷GFP rescued the
egl-26(ku228) Egl phenotype as efficiently as EGL-26∷GFP
(Fig. 4). While we can observe differences in intensity of
expression among individuals within a transgenic strain as
expected when using extrachromosomal arrays, we see noTare required for EGL-26 function in vivo. Schematic showing mutated residues
t are important for catalysis. Histogram showing egg-laying percentage of egl-26
r EGL-26∷GFP protein with the indicated alanine substitution mutation. Actual
ample sizes (n) are indicated to the right of each bar.
Fig. 5. Mutation of putative catalytic residues in EGL-26 does not alter expression. (A, C, E, G) DIC photomicrographs and (B, D, F, H) corresponding fluorescent
images of egl-26(ku228) mutants expressing the indicated extra-chromosomal arrays at mid-L4-stage. (A, B) psEx84[EGL-26∷GFP]. (C, D) psEx36 [EGL-26
(H178A)∷GFP]. (E, F) psEx37[EGL-26(H166A)∷GFP]. (G, H) psEx43[EGL-26(C261A)∷GFP]. All GFP fusion proteins are concentrated at the apical membrane.
Scale bar: 10 μm.
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animals from each strain, we cannot detect any significant
differences in expression among the functional and non-
functional transgenes. We conclude that the non-functional
GFP fusion proteins are expressed with the same intensity in the
vulva and exhibit the same sub-cellular localization patterns as
the functional fusions (Fig. 5).
Serine 275 is important for EGL-26 function in vivo
The EMS-induced egl-26 allele, n481, is a substitution of
phenylalanine for conserved serine 275 near the end of the NC
domain (Fig. 1). EGL-26(S275F)∷GFP has no activity as
assayed by its ability to rescue the Egl defect of egl-26(ku211)
animals (Fig. 7). Furthermore, EGL-26(S275F)∷GFP localizes
to the cytoplasm rather than at the apical membrane (Fig. 6D).
We analyzed the effects of additional serine 275 substitutionFig. 6. Mutation of serine 275 can alter the sub-cellular localization of EGL-26. (A
fluorescent images of two lateral vulE cells at the mid-L4-stage. (A, B) kuEx90[EGL-
26(S275F)∷GFP] has a diffuse, generally cytoplasmic localization. (E, F) psEx
concentrated. (G, H) psEx77[EGL-26(S275E)∷GFP] has a diffuse, generally cytopla
at the apical membrane but is also present in cytoplasm. (K, L) psEx86[EGL-26(S275
cytoplasm. The localization shown here was consistent for all transgenic lines testedmutations on EGL-26 function and localization. We created the
phosphomimetic mutation S275E because predictions using
NetPhos 2.0 (Blom et al., 1999) suggest that serine 275 is highly
likely to be phosphorylated. In addition, we substituted alanine
and threonine residues instead of the bulky hydrophobic
phenylalanine found in the mutant.
Insertion of a glutamate did not restore function or sub-
cellular localization to EGL-26. EGL-26(S275E)∷GFP cannot
provide egg-laying activity in the rescue assay (Fig. 7), and this
mutant was not localized to the membrane (Fig. 6H). However,
both the threonine and alanine substitution mutations were
permissive for function. Transgenes encoding these proteins
provided between 78% and 94% of the function provided by a
wild-type protein (Fig. 7). These proteins were also slightly
enriched at the apical membrane (Figs. 6J, L) relative to EGL-
26(S275F), which was never concentrated at the apical
membrane but was easily visible in the cytoplasm (Fig. 6D)., C, E, G, I, K) DIC photomicrographs and (B, D, F, H, J, L) corresponding
26∷GFP] is concentrated at the apical membrane of vulE. (C, D) psEx112[EGL-
25[EGL-26(S275F)∷GFP∷CAAX] is membrane localized, but not apically
smic localization. (I, J) psEx85[EGL-26(S275A)∷GFP] is partially concentrated
T)∷GFP] is partially concentrated at the apical membrane but is also present in
. Scale bar: 10 μm.
Fig. 7. Serine 275 is important for EGL-26 function and membrane localization correlates with function. Schematic showing mutated Ser275 in EGL-26 and the site of
the GFP and CAAX fusions. Histogram showing egg-laying percentage of egl-26(ku211) mutant populations carrying transgenes encoding wild-type EGL-26∷GFP
or the indicated EGL-26∷GFP variant. The two bars represent separate transgenic lines generated for each construct. EGL-26(S275F) is mis-localized (Figs. 6C, D)
and does not rescue the egg-laying defect of egl-26(ku211). Restoring membrane localization to EGL-26(S275F)∷GFP with a CAAX prenylation signal (Figs. 6E, F)
increases its egg-laying ability to at least twice that of EGL-26(S275F) alone, resulting in a partial rescue of the Egl phenotype. Similar to EGL-26(S275F), EGL-26
(S275E) also does not rescue the mutant. EGL-26∷GFP∷CAAX retains the egg-laying ability of EGL-26∷GFP. EGL-26(S275A) and one of the two lines of EGL-26
(S275T) partially rescue the mutant, while the other line of EGL-26(S275T) rescues egg-laying ability as efficiently as EGL-26∷GFP. Error bars indicate a 95%
confidence interval. Sample sizes (n) are indicated to the right of each bar.
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regain a slight enrichment at the apical membrane, each is still
overabundant in the cytoplasm relative to EGL-26∷GFP (Fig.
6). We conclude that serine 275 plays a role in membrane
localization and mutation of this residue likely affects protein
function more generally as well.
Membrane localization plays a role in EGL-26 function
Intriguingly, when the H-box and NC domains were first
recognized, they were noted to occur in combination with
predicted transmembrane domains (Hughes and Stanway,
2000). LRAT has a C-terminal transmembrane domain that
results in a topology with the catalytic domain in the cytoplasm
(Moise et al., 2007; Ruiz et al., 1999). Hrasls3 has a predicted
transmembrane domain, and at least a subset of the cellular
protein is associated with membranes (Hajnal et al., 1994; Sers
et al., 1997). Unlike the other H-box/NC domain-containing
eukaryotic proteins, EGL-26 has no strongly predicted alpha-
helical, membrane-spanning region (Claros and Heijne, 1994;
Krogh et al., 2001; von Heijne, 1992). However, EGL-26 is
specifically localized at or near the apical membrane in cells
where it is expressed (Hanna-Rose and Han, 2002).
These observations, coupled with the data indicating that
serine 275 plays a role in localization, led us to hypothesize that
membrane localization may be required for function and that
perhaps EGL-26(S275F) did not function because it wasavailable at the membrane only a fraction of the time, if at all.
Based on this hypothesis, we predicted that if we could increase
the fraction of EGL-26(S275F) at the membrane, we could
increase its activity. To test this prediction, we incorporated a
CAAX motif (CNIM) at the C-terminus of EGL-26
(S275F)∷GFP (Fig. 7). The C-terminal CAAX motif is a
prenylation signal and results in lipid modification and
subsequent membrane localization of the covalently linked
protein (Maurer-Stroh et al., 2003). Addition of the CAAX
motif to EGL-26(S275F)∷GFP induced localization to the
membrane but not specifically to the apical surface, as expected
(Fig. 6). Interestingly, the plasma membrane bound EGL-26
(S275F)∷GFP∷CAAX protein had increased activity and an
egg-laying percentage at least twice that of EGL-26
(S275F)∷GFP (Fig. 7). As a control, we also confirmed that
tethering the GFP to the membrane via its C-terminus had no
effect on EGL-26∷GFP activity (EGL-26∷GFP∷CAAX; Fig.
7). We conclude that membrane localization contributes to
EGL-26 function and serine 275 plays a role in localization.
Discussion
Primary vulval fates are normally specified in egl-26 mutants
but late aspects of morphogenesis are abnormal
In an egl-26 mutant, the most obvious defect is the distorted
shape of the polarized epithelial vulval cell called vulF. Our
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(Hanna-Rose and Han, 2002) demonstrate that vulF is properly
polarized in egl-26 mutants. Despite the observation that vulF
somewhat resembles vulE in egl-26 mutants (Hanna-Rose and
Han, 2002), expression of vulE-specific and vulF-specific
markers are restricted to the expected cell types (Fig. 2). Early
morphogenesis of vulF during AC invasion is normal in the
mutants (Fig. 3), and uv1 fate is induced (Fig. 2). Taken
together, our results demonstrate that (1) vulF fate specification,
(2) early morphogenesis of the vulF cell, including establish-
ment and maintenance of cell polarity, and (3) vulF–uterine
cell–cell signaling capabilities are maintained in the egl-26
mutant. We conclude that egl-26 acts quite specifically in a late
stage of vulF cell morphogenesis. Our conclusion is consistent
with the observation that EGL-26∷GFP expression is first
observed relatively late in morphogenesis, during the mid-L4
stage (Hanna-Rose and Han, 2002).
EGL-26 acts to ensure the fidelity of vulF morphogenesis
All EMS-induced alleles of egl-26 cause missense mutations
that result in an incompletely penetrant vulF cell morphology
defect. After analyses of the EMS-induced alleles, it was
unclear if the incomplete penetrance was due to weak, loss-of-
function effects or due to a function for EGL-26 in ensuring
consistent results during morphogenesis, as opposed to an
absolute requirement for the protein. Attempts to address this
question using RNAi to phenocopy a null or loss-of-function
phenotype have failed. We observe only a 4% Egl phenotype
upon RNAi of egl-26, and genome-wide screens have similarly
failed to reveal any egl-26(RNAi) effect (Kamath et al., 2003;
Rual et al., 2004; Sonnichsen et al., 2005). We have now
addressed the question of gene function by examining a deletion
allele of egl-26. egl-26(tm1244) behaves genetically like a null
allele and completely lacks the sequences that define the NlpC/
P60 family, specifically residues H166 and C261, which are
critical for function as demonstrated by our mutagenesis
experiments. Thus, any protein encoded by egl-26(tm1244) is
unlikely to retain function. Yet, egl-26(tm1244) is also
incompletely penetrant. We suggest that although EGL-26
promotes appropriate morphogenesis of vulF, it is unlikely to be
absolutely required for normal vulF morphogenesis. Interest-
ingly, we have observed that two of the EMS-derived mutations
(ku228 and ku211) have a more penetrant Egl phenotype than
egl-26(tm1244). No egl-26 alleles have any dominant properties
and all are rescued by expression of the wild-type protein.
Nonetheless, the unusual higher penetrance of ku228 and ku211
relative to the putative molecular null tm1244 hint at the
possibility of a more complicated genetic function for these
alleles in vulval morphogenesis.
EGL-26 is an NlpC/P60 protein and is likely to have a
biochemical function similar to LRAT
egl-26(ku228), the most penetrant of the EMS-induced
alleles, affects glycine residue 150 (Fig. 1), which is conserved
in 95% of proteins in the LRAT subfamily (Anantharaman andAravind, 2003). The EMS-induced egl-26 alleles ku211 and
n481 encode proteins with mutations at G168 and S275,
which are both perfectly conserved in the LRAT subfamily but
not in the wider superfamily. These observations suggest that
G150, G168 and S275 may be important for function in the
LRAT subfamily of eukaryotic proteins. The positions of these
mutations highlight the importance of the likely LRAT-like
biochemical activity to the developmental function of EGL-26
and suggest that all egl-26 alleles result in a significant
reduction-of-function.
NlpC/P60 superfamily members perform an array of
functions in prokaryotes but are not as well studied in higher
eukaryotes (Anantharaman and Aravind, 2003). We have shown
that the residues His166 and Cys261, which are conserved
throughout the larger superfamily and are required for catalysis
in LRAT (Anantharaman and Aravind, 2003; Xue et al., 2004),
are essential for EGL-26 function in vivo. Our results
specifically illustrate the importance of the catalytic residues
and an LRAT-like catalytic activity in an animal developmental
morphogenesis context.
Because our data suggest that EGL-26 has catalytic activity
similar to that of LRAT, we speculate that EGL-26 may be
acting as an acyltransferase to facilitate morphogenesis of the
vulF cell. Due to the importance of membrane localization to
EGL-26 function, it is possible that EGL-26 palmitoylates a
selection of membrane proteins that are important for
morphogenesis. Mosaic analysis of egl-26 is consistent with a
role for the gene in either vulF or vulE, but expression is
consistently detected in vulE only (Hanna-Rose and Han,
2002). Thus, we have speculated that EGL-26 may function
non-cell-autonomously. In that case, EGL-26 could lipid
modify a signaling molecule that is required by vulF to undergo
the last stages of morphogenesis. There is ample precedence for
such modifications of secreted molecules in development
(Miura and Treisman, 2006).
EGL-26 membrane localization is correlated with function
EGL-26(S275F)∷GFP is mis-localized to the cytoplasm and
does not function in the Egl rescue assay. Interestingly, a
mutation of the corresponding serine residue in LRAT to
arginine (S175R) has been identified in humans with early-onset
retinal dystrophy (Thompson et al., 2001). Furthermore, LRAT
(S175R) retained no enzymatic activity, indicating that Serine
175 is essential for LRAT activity (Thompson et al., 2001).
Localization of LRAT(S175R) was not reported. However, this
protein retains its transmembrane domain and so would
presumably be localized to the membrane if expressed.
Substitution of the hydrophobic phenylalanine or phospho-
mimetic-charged glutamic acid for serine 275 cannot support
protein function, but localization of EGL-26(S275F)∷GFP to
the membrane using a CAAX motif increases its function. This
suggests that membrane localization is important for EGL-26
function and that EGL-26(S275F)∷GFP is at least partially
functional if available at the membrane. Interestingly, substitu-
tion of the smaller residues alanine and threonine at position
275 can support protein function. We reason that the likely
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localization as well as activity as opposed to specifically
affecting membrane affinity. This indicates that the mechanism
of protein localization for EGL-26 is likely to be via a protein–
protein interaction as opposed to a cryptic membrane-spanning
region or lipid modification of a specific linear amino acid
motif. This conclusion is supported by our unpublished
observation that the N-terminal third, the middle third and
the C-terminal third of EGL-26 are each insufficient to direct
membrane localization of EGL-26. Instead, we suggest that
EGL-26 is unique in the LRAT sub-family of NlpC/P60
proteins in its mechanism for attaining membrane localization.
We also conclude that membrane localization correlates with
function, as only mutants that exhibit membrane localization
function in the Egl rescue assay and restoration of membrane
localization to a cytosolically localized mutant increases
protein function. The conserved serine 275 residue clearly
plays a role in EGL-26 function, and we will continue our
investigations of this residue as it will provide insight into the
protein's biochemical function as well as the purpose and
mechanism of protein localization.
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